How to make your messages on tuberculosis count
WHO/HTM/STB/2009.57
Guidelines for social mobilization
TB and poverty; TB and children; TB and women; TB, migrants and refugees; TB and prisons
WHO/CDS/STB/2001.9
Original: English; Distribution: Limited
Advocacy, communication and social mobilization for TB control
A Handbook for country programmes
Advocacy report March 2011
303100 03/2011 E 1,000
Overcoming Barriers to TB Control
Training Curriculum
August 2011
Во всем мире распространенность туберкулеза гораздо выше
в городских районах, чем в сельских. Около 54 % мирового населения
проживает в городах, а развивающиеся ст...аны показывают наиболее
высокие темпы урбанизации. В развитых странах урбанизация привела
к всеобщему улучшению здравоохранения, однако данная тенденция
не нашла отражения в менее развитых регионах мира. В таких странах
ключевые социальные и экономические детерминанты туберкулеза
сходятся на самых бедных группах населения. краткое руководство
Accessed on 2017
more
TB policies in 24 Countries
A survey of prevention, testing and treatment policies and practices
Лечение туберкулеза в 24 странах
Исследование диагностической и клинической практики
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Tuberculosis MDR-TB & XDR-TB The 2008 Report
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.
more
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Rapport sur les populations clès
Accessed November 2017
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
A compendium of TB REACH case studies, lessons learned and a monitoring and evaluation framework.
Accessed November 2017.
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
Technical information note. Digital Adherence Technologies (DATs) such as the smart medication container
kit can help to support people affected by TB with their treatment in a modern
and ef-fective way. These technologies are able to deliver reminders and may
help em-power TB affected individual...s and their families to take their daily
medication at a time and place that suits them best. They also generate a
digital record of medication intake.
more
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
and delivering more than $200 million worth of diagnostic equipment
more